title: [Cardiology news 2009: arterial hypertension, primary and secondary prevention of atherosclerosis, antithrombotic therapy].
authors.forename: Zh D
authors.initials: ZhD
authors.lastname: Kobalava
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Kotovskaia
authors.forename: S V
authors.initials: SV
authors.lastname: Villeval'de
authors.forename: O A
authors.initials: OA
authors.lastname: Averkov
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000517:prevention & control* / Q000628:therapy; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002309:Cardiology; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D018849:Controlled Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005060:Europe; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D012307:Risk Factors; D013997:Time Factors; D014481:United States
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D005343:Fibrinolytic Agents